178 related articles for article (PubMed ID: 37309681)
1.
Mohammadzadeh R; Menbari S; Pishdadian A; Farsiani H
Expert Rev Mol Med; 2023 Jun; 25():e23. PubMed ID: 37309681
[No Abstract] [Full Text] [Related]
2. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Latin American-specific BabA adhesin variant through whole genome sequencing of Helicobacter pylori patient isolates from Nicaragua.
Thorell K; Hosseini S; Palacios Gonzáles RV; Chaotham C; Graham DY; Paszat L; Rabeneck L; Lundin SB; Nookaew I; Sjöling Å
BMC Evol Biol; 2016 Feb; 16():53. PubMed ID: 26928576
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori adhesins: HpaA a potential antigen in experimental vaccines for H. pylori.
Banga Ndzouboukou JL; Lei Q; Ullah N; Zhang Y; Hao L; Fan X
Helicobacter; 2021 Feb; 26(1):e12758. PubMed ID: 33259676
[TBL] [Abstract][Full Text] [Related]
5. The sialic acid binding SabA adhesin of Helicobacter pylori is essential for nonopsonic activation of human neutrophils.
Unemo M; Aspholm-Hurtig M; Ilver D; Bergström J; Borén T; Danielsson D; Teneberg S
J Biol Chem; 2005 Apr; 280(15):15390-7. PubMed ID: 15689619
[TBL] [Abstract][Full Text] [Related]
6. Potential antigen candidates for subunit vaccine development against Helicobacter pylori infection.
Keikha M; Eslami M; Yousefi B; Ghasemian A; Karbalaei M
J Cell Physiol; 2019 Dec; 234(12):21460-21470. PubMed ID: 31188484
[TBL] [Abstract][Full Text] [Related]
7. Immune Evasion Strategies and Persistence of Helicobacter pylori.
Mejías-Luque R; Gerhard M
Curr Top Microbiol Immunol; 2017; 400():53-71. PubMed ID: 28124149
[TBL] [Abstract][Full Text] [Related]
8. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation.
Prinz C; Schöniger M; Rad R; Becker I; Keiditsch E; Wagenpfeil S; Classen M; Rösch T; Schepp W; Gerhard M
Cancer Res; 2001 Mar; 61(5):1903-9. PubMed ID: 11280745
[TBL] [Abstract][Full Text] [Related]
9.
Doohan D; Rezkitha YAA; Waskito LA; Yamaoka Y; Miftahussurur M
Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357957
[No Abstract] [Full Text] [Related]
10. Increased Risk of Severe Gastric Symptoms by Virulence Factors
Lee DH; Ha JH; Shin JI; Kim KM; Choi JG; Park S; Park JS; Seo JH; Park JS; Shin MK; Baik SC; Lee WK; Youn HS; Cho MJ; Kang HL; Jung M
J Microbiol Biotechnol; 2021 Mar; 31(3):368-379. PubMed ID: 33622995
[TBL] [Abstract][Full Text] [Related]
11. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors.
Franco AT; Johnston E; Krishna U; Yamaoka Y; Israel DA; Nagy TA; Wroblewski LE; Piazuelo MB; Correa P; Peek RM
Cancer Res; 2008 Jan; 68(2):379-87. PubMed ID: 18199531
[TBL] [Abstract][Full Text] [Related]
12. Precancerous Gastric Lesions with
Bartpho TS; Wattanawongdon W; Tongtawee T; Paoin C; Kangwantas K; Dechsukhum C
Biomed Res Int; 2020; 2020():7243029. PubMed ID: 32149129
[TBL] [Abstract][Full Text] [Related]
13. Immune evasion strategies used by Helicobacter pylori.
Lina TT; Alzahrani S; Gonzalez J; Pinchuk IV; Beswick EJ; Reyes VE
World J Gastroenterol; 2014 Sep; 20(36):12753-66. PubMed ID: 25278676
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori evasion strategies of the host innate and adaptive immune responses to survive and develop gastrointestinal diseases.
Karkhah A; Ebrahimpour S; Rostamtabar M; Koppolu V; Darvish S; Vasigala VKR; Validi M; Nouri HR
Microbiol Res; 2019 Jan; 218():49-57. PubMed ID: 30454658
[TBL] [Abstract][Full Text] [Related]
15. Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders.
Nejati S; Karkhah A; Darvish H; Validi M; Ebrahimpour S; Nouri HR
Microb Pathog; 2018 Apr; 117():43-48. PubMed ID: 29432909
[TBL] [Abstract][Full Text] [Related]
16. No correlation of babA2 with vacA and cagA genotypes of Helicobacter pylori and grading of gastritis from peptic ulcer disease patients in Brazil.
Mattar R; dos Santos AF; Eisig JN; Rodrigues TN; Silva FM; Lupinacci RM; Iriya K; Carrilho FJ
Helicobacter; 2005 Dec; 10(6):601-8. PubMed ID: 16302986
[TBL] [Abstract][Full Text] [Related]
17. Effects of
Nguyen QA; Schmitt L; Mejías-Luque R; Gerhard M
Front Immunol; 2023; 14():1113478. PubMed ID: 36891299
[No Abstract] [Full Text] [Related]
18. Impact of
Roshrosh H; Rohana H; Azrad M; Leshem T; Masaphy S; Peretz A
World J Gastroenterol; 2023 Jan; 29(1):190-199. PubMed ID: 36683715
[TBL] [Abstract][Full Text] [Related]
19. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori.
Salama NR; Hartung ML; Müller A
Nat Rev Microbiol; 2013 Jun; 11(6):385-99. PubMed ID: 23652324
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori virulence factors and the host immune response: implications for therapeutic vaccination.
Prinz C; Hafsi N; Voland P
Trends Microbiol; 2003 Mar; 11(3):134-8. PubMed ID: 12648945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
